1. Home
  2. RVPH vs ARBK Comparison

RVPH vs ARBK Comparison

Compare RVPH & ARBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • ARBK
  • Stock Information
  • Founded
  • RVPH 2006
  • ARBK 2017
  • Country
  • RVPH United States
  • ARBK United Kingdom
  • Employees
  • RVPH N/A
  • ARBK N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • ARBK Finance: Consumer Services
  • Sector
  • RVPH Health Care
  • ARBK Finance
  • Exchange
  • RVPH Nasdaq
  • ARBK Nasdaq
  • Market Cap
  • RVPH 26.6M
  • ARBK 21.6M
  • IPO Year
  • RVPH N/A
  • ARBK 2021
  • Fundamental
  • Price
  • RVPH $0.54
  • ARBK $0.30
  • Analyst Decision
  • RVPH Strong Buy
  • ARBK Hold
  • Analyst Count
  • RVPH 5
  • ARBK 1
  • Target Price
  • RVPH $8.00
  • ARBK N/A
  • AVG Volume (30 Days)
  • RVPH 2.8M
  • ARBK 2.0M
  • Earning Date
  • RVPH 08-14-2025
  • ARBK 08-27-2025
  • Dividend Yield
  • RVPH N/A
  • ARBK N/A
  • EPS Growth
  • RVPH N/A
  • ARBK N/A
  • EPS
  • RVPH N/A
  • ARBK N/A
  • Revenue
  • RVPH N/A
  • ARBK $47,017,000.00
  • Revenue This Year
  • RVPH N/A
  • ARBK $183.90
  • Revenue Next Year
  • RVPH N/A
  • ARBK $26.78
  • P/E Ratio
  • RVPH N/A
  • ARBK N/A
  • Revenue Growth
  • RVPH N/A
  • ARBK N/A
  • 52 Week Low
  • RVPH $0.30
  • ARBK $0.15
  • 52 Week High
  • RVPH $4.28
  • ARBK $1.55
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 61.01
  • ARBK 46.08
  • Support Level
  • RVPH $0.40
  • ARBK $0.30
  • Resistance Level
  • RVPH $0.48
  • ARBK $0.34
  • Average True Range (ATR)
  • RVPH 0.05
  • ARBK 0.03
  • MACD
  • RVPH 0.01
  • ARBK -0.00
  • Stochastic Oscillator
  • RVPH 58.53
  • ARBK 28.11

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About ARBK Argo Blockchain plc

Argo Blockchain PLC is a blockchain technology company focused on the large-scale mining of Bitcoin. It mines bitcoin using purpose-built computers (or mining machines) to solve complex cryptographic algorithms on the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company acquires and deploys mining technology solutions in North American facilities that utilize predominantly renewable and inexpensive electricity.

Share on Social Networks: